药物洗脱支架：前进一小步，后退两步——从预防再狭窄到引发晚期血栓形成和新生动脉粥样硬化。 - Suppr

Suppr

超能文献

One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.

作者信息

Nakazawa Gaku, Vorpahl Marc, Finn Aloke V, Narula Jagat, Virmani Renu

出版信息

JACC Cardiovasc Imaging. 2009 May;2(5):625-8. doi: 10.1016/j.jcmg.2009.01.011.

DOI:10.1016/j.jcmg.2009.01.011

PMID:19442951

Abstract

摘要

相似文献

One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.

JACC Cardiovasc Imaging. 2009 May;2(5):625-8. doi: 10.1016/j.jcmg.2009.01.011.

Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?

JACC Cardiovasc Interv. 2009 Apr;2(4):300-2. doi: 10.1016/j.jcin.2009.01.004.

Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.

JACC Cardiovasc Imaging. 2009 May;2(5):616-24. doi: 10.1016/j.jcmg.2008.12.026.

IVUS and OCT: either or survivor ….

JACC Cardiovasc Imaging. 2011 Sep;4(9):1047-9. doi: 10.1016/j.jcmg.2011.08.002.

A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.

EuroIntervention. 2011 May;7 Suppl K:K93-9. doi: 10.4244/EIJV7SKA16.

Nevo stent: a successful stent makeover.

Catheter Cardiovasc Interv. 2011 Jan 1;77(1):52-3. doi: 10.1002/ccd.22921.

Neointimal coverage over coronary stent struts crossing the side branch Ostia.

Circ J. 2011;75(1):51-2. doi: 10.1253/circj.cj-10-1147.

Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography.

JACC Cardiovasc Imaging. 2011 Nov;4(11):1217-9. doi: 10.1016/j.jcmg.2011.05.008.

NEVO™: a new generation of sirolimus-eluting coronary stent.

EuroIntervention. 2009 Dec 15;5 Suppl F:F88-93. doi: 10.4244/EIJV5IFA15.

Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.

Arch Cardiovasc Dis. 2011 Mar;104(3):147-54. doi: 10.1016/j.acvd.2010.12.004. Epub 2011 Mar 26.

引用本文的文献

Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.

Eur Heart J. 2025 Jul 7;46(26):2498-2519. doi: 10.1093/eurheartj/ehaf029.

Mechanisms of ferroptosis and glucagon-like peptide-1 receptor agonist in post-percutaneous coronary intervention restenosis.

Mol Cell Biochem. 2025 Mar;480(3):1465-1480. doi: 10.1007/s11010-024-05118-6. Epub 2024 Sep 16.

Research Progress on the Pathogenesis and Treatment of Neoatherosclerosis.

Curr Med Sci. 2024 Aug;44(4):680-685. doi: 10.1007/s11596-024-2915-x. Epub 2024 Aug 3.

Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study).

BMJ Open. 2024 Jul 15;14(7):e083730. doi: 10.1136/bmjopen-2023-083730.

Efficacy and safety of drug-coated balloons in chronic total coronary occlusion recanalization: a systematic review and meta-analysis.

BMC Cardiovasc Disord. 2024 Jun 26;24(1):324. doi: 10.1186/s12872-024-03993-x.

Nanogold-coated stent facilitated non-invasive photothermal ablation of stent thrombosis and restoration of blood flow.

Nanoscale Adv. 2024 Jan 30;6(5):1497-1506. doi: 10.1039/d3na00751k. eCollection 2024 Feb 27.

Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in coronary chronic total occlusion intervention: A multicenter observational study.

Front Cardiovasc Med. 2023 Mar 3;10:1045859. doi: 10.3389/fcvm.2023.1045859. eCollection 2023.

Clinical Outcomes of Drug-Coated Balloon Treatment After Successful Revascularization of Chronic Total Occlusions.

Front Cardiovasc Med. 2022 Apr 13;9:821380. doi: 10.3389/fcvm.2022.821380. eCollection 2022.

The Mechanisms of Restenosis and Relevance to Next Generation Stent Design.

Biomolecules. 2022 Mar 10;12(3):430. doi: 10.3390/biom12030430.

The role of intracoronary imaging in translational research.

Cardiovasc Diagn Ther. 2020 Oct;10(5):1480-1507. doi: 10.21037/cdt-20-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.

作者信息

Nakazawa Gaku, Vorpahl Marc, Finn Aloke V, Narula Jagat, Virmani Renu

出版信息

JACC Cardiovasc Imaging. 2009 May;2(5):625-8. doi: 10.1016/j.jcmg.2009.01.011.

DOI:10.1016/j.jcmg.2009.01.011

PMID:19442951

Abstract

摘要

相似文献

One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.

JACC Cardiovasc Imaging. 2009 May;2(5):625-8. doi: 10.1016/j.jcmg.2009.01.011.

Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?

JACC Cardiovasc Interv. 2009 Apr;2(4):300-2. doi: 10.1016/j.jcin.2009.01.004.

Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.

JACC Cardiovasc Imaging. 2009 May;2(5):616-24. doi: 10.1016/j.jcmg.2008.12.026.

IVUS and OCT: either or survivor ….

JACC Cardiovasc Imaging. 2011 Sep;4(9):1047-9. doi: 10.1016/j.jcmg.2011.08.002.

EuroIntervention. 2011 May;7 Suppl K:K93-9. doi: 10.4244/EIJV7SKA16.

Nevo stent: a successful stent makeover.

Catheter Cardiovasc Interv. 2011 Jan 1;77(1):52-3. doi: 10.1002/ccd.22921.

Neointimal coverage over coronary stent struts crossing the side branch Ostia.

Circ J. 2011;75(1):51-2. doi: 10.1253/circj.cj-10-1147.

Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography.

JACC Cardiovasc Imaging. 2011 Nov;4(11):1217-9. doi: 10.1016/j.jcmg.2011.05.008.

NEVO™: a new generation of sirolimus-eluting coronary stent.

EuroIntervention. 2009 Dec 15;5 Suppl F:F88-93. doi: 10.4244/EIJV5IFA15.

Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.

Arch Cardiovasc Dis. 2011 Mar;104(3):147-54. doi: 10.1016/j.acvd.2010.12.004. Epub 2011 Mar 26.

引用本文的文献

Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.

Eur Heart J. 2025 Jul 7;46(26):2498-2519. doi: 10.1093/eurheartj/ehaf029.

Mechanisms of ferroptosis and glucagon-like peptide-1 receptor agonist in post-percutaneous coronary intervention restenosis.

Mol Cell Biochem. 2025 Mar;480(3):1465-1480. doi: 10.1007/s11010-024-05118-6. Epub 2024 Sep 16.

Research Progress on the Pathogenesis and Treatment of Neoatherosclerosis.

Curr Med Sci. 2024 Aug;44(4):680-685. doi: 10.1007/s11596-024-2915-x. Epub 2024 Aug 3.

BMJ Open. 2024 Jul 15;14(7):e083730. doi: 10.1136/bmjopen-2023-083730.

Efficacy and safety of drug-coated balloons in chronic total coronary occlusion recanalization: a systematic review and meta-analysis.

BMC Cardiovasc Disord. 2024 Jun 26;24(1):324. doi: 10.1186/s12872-024-03993-x.

Nanogold-coated stent facilitated non-invasive photothermal ablation of stent thrombosis and restoration of blood flow.

Nanoscale Adv. 2024 Jan 30;6(5):1497-1506. doi: 10.1039/d3na00751k. eCollection 2024 Feb 27.

Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in coronary chronic total occlusion intervention: A multicenter observational study.

Front Cardiovasc Med. 2023 Mar 3;10:1045859. doi: 10.3389/fcvm.2023.1045859. eCollection 2023.

Clinical Outcomes of Drug-Coated Balloon Treatment After Successful Revascularization of Chronic Total Occlusions.

Front Cardiovasc Med. 2022 Apr 13;9:821380. doi: 10.3389/fcvm.2022.821380. eCollection 2022.

The Mechanisms of Restenosis and Relevance to Next Generation Stent Design.

Biomolecules. 2022 Mar 10;12(3):430. doi: 10.3390/biom12030430.

The role of intracoronary imaging in translational research.

Cardiovasc Diagn Ther. 2020 Oct;10(5):1480-1507. doi: 10.21037/cdt-20-1.